New Clinical Practice Guidelines and Strategies in Obesity Management
New Clinical Practice Guidelines and Strategies in Obesity Management
Target Audience
This continuing medical education activity should be of substantial interest to endocrinologists, endocrine fellows, and healthcare professionals who treat patients with obesity.
Learning Objectives
Upon completion of this educational activity, learners will be better able to:
- Stratify risks and discuss the clinical recommendations and benefits of sustained weight loss in overweight and obese patients
- Describe the role of hormonal and neural mechanisms in the regulation of appetite, food intake, and body weight
- Discuss current strategies for reducing weight gain and promoting weight loss
- Discuss the efficacy and safety of new and emerging treatment options in obesity management
- Apply updated practice guidelines in a clinical setting
Additional Information
Marc Cornier, MD – Program Moderator
Assistant Professor
Department of Medicine
Denver Health Medical Center
Denver, Colorado
Daniel Bessesen, MD
Chief of Endocrinology
Denver Health Medical Center
Professor of Medicine
University of Colorado
Denver, Colorado
Disclosure Policy
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Daniel H. Bessesen, MD: DSMB Member, Enteromedics
The following faculty reported no relevant financial relationships: Marc Cornier, MD
The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships: Connie B Newman, MD
The following SPC Committee members reported relevant financial relationships:
Sarah Berga, MD: Advisory Board Member, Agile Therapeutics, Noven Pharmaceuticals, Inc., Watson Pharmaceuticals, Teva Pharmaceuticals Industries, Shionogi, Inc.; Consultant, AHC Media, LLC, Shionogi, Inc.
Paresh Dandona, MD, PhD, FRCP: Consultant and Speaker, AstraZeneca, Bristol Myers Squibb, Janssen, Merck, Novo Nordisk
Irl B Hirsch, MD: Consultant, Abbott Laboratories, Becton Dickinson, Roche Diagnostics; Grant Support, Halozyme, Sanofi
E. Michael Lewiecki, MD: Consultant, Amgen, Eli Lilly, Merck, Radius Health, AgNovos Healthcare, Theranova; Research Grant Support, Amgen, Eli Lilly, Merck;
Anton Luger, MD: Advisory Board Member, Investigator and Speaker, Novo Nordisk; Advisory Board Member and Speaker, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Ipsen, Merck, Merck, Sharp & Dome, Novartis, Pfizer, Reckitt Benkiser, Takeda; Investigator, Roche
Guillermo E Umpierrez, MD, CDE: Advisory Board and Consultant, Abbott, Boehringer Ingelheim, Merck, Novo Nordisk, Regeneron, Sanofi; Research Grant Support, Boehringer Ingelheim, Merck & Co., Novo Nordisk, Regeneron
Andrea L Utz, MD, PhD: Investigator, Corcept, Ipsen
The following SPC members reported no relevant financial relationships: Jeffrey Boord, MD, MPH; Larry Fox, MD; Michael S Irwig, MD
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 CME Certificate of Participation